ZA88577B - Use of pyridoxine derivatives in the prevention and treatment of hyperlipidaemia and atherosclerosis - Google Patents
Use of pyridoxine derivatives in the prevention and treatment of hyperlipidaemia and atherosclerosisInfo
- Publication number
- ZA88577B ZA88577B ZA880577A ZA88577A ZA88577B ZA 88577 B ZA88577 B ZA 88577B ZA 880577 A ZA880577 A ZA 880577A ZA 88577 A ZA88577 A ZA 88577A ZA 88577 B ZA88577 B ZA 88577B
- Authority
- ZA
- South Africa
- Prior art keywords
- hyperlipidaemia
- atherosclerosis
- treatment
- pyridoxine
- prevention
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Pyridine Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19873705549 DE3705549A1 (de) | 1987-02-18 | 1987-02-18 | Verwendung von pyridoxin-derivaten bei der prophylaxe und therapie von hyperlipidaemien und atherosklerose |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA88577B true ZA88577B (en) | 1988-07-28 |
Family
ID=6321453
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA880577A ZA88577B (en) | 1987-02-18 | 1988-01-28 | Use of pyridoxine derivatives in the prevention and treatment of hyperlipidaemia and atherosclerosis |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP0282696B1 (hu) |
JP (2) | JPH0710777B2 (hu) |
KR (1) | KR950009094B1 (hu) |
AT (1) | ATE82125T1 (hu) |
CA (1) | CA1340246C (hu) |
DE (2) | DE3705549A1 (hu) |
DK (1) | DK55888A (hu) |
EG (1) | EG18335A (hu) |
ES (1) | ES2052609T3 (hu) |
GR (1) | GR3006693T3 (hu) |
HU (1) | HUT47850A (hu) |
ZA (1) | ZA88577B (hu) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6228858B1 (en) | 1995-09-12 | 2001-05-08 | University Of Kansas Medical Center | Advanced glycation end-product intermediaries and post-amadori inhibition |
US6716858B1 (en) | 1995-08-28 | 2004-04-06 | Kansas University Medical Center | Methods for inhibiting diabetic complications |
US6740668B1 (en) | 1995-08-28 | 2004-05-25 | Kansas University Medical Center | Methods for inhibiting diabetic complications |
US6750209B1 (en) | 1995-09-12 | 2004-06-15 | Kansas University Medical Center | Advanced glycation end-product intermediaries and post-amadori inhibition |
US5744451A (en) | 1995-09-12 | 1998-04-28 | Warner-Lambert Company | N-substituted glutamic acid derivatives with interleukin-1 β converting enzyme inhibitory activity |
US6730686B1 (en) | 1995-09-12 | 2004-05-04 | Kansas University Medical Center | Methods for inhibiting oxidative modification of proteins |
US7030146B2 (en) | 1996-09-10 | 2006-04-18 | University Of South Carolina | Methods for treating diabetic neuropathy |
US6043259A (en) * | 1998-07-09 | 2000-03-28 | Medicure Inc. | Treatment of cardiovascular and related pathologies |
AU1444600A (en) * | 1998-10-09 | 2000-05-01 | Kansas University Medical Center | Methods for inhibiting oxidative modification of proteins |
US6339085B1 (en) | 1999-03-08 | 2002-01-15 | The University Of Manitoba | Therapeutics for cardiovascular and related diseases |
EP1196171A2 (en) | 1999-07-13 | 2002-04-17 | Medicure Inc. | Use of pyridoxin derivatives for the treatment of diabetes and related complications |
WO2001013900A2 (en) | 1999-08-24 | 2001-03-01 | Medicure International Inc. | Compositions for the treatment of cardiovascular diseases containing pyridoxal compounds and cardiovascular compounds |
JP2003525303A (ja) | 2000-02-29 | 2003-08-26 | メディキュア インターナショナル インコーポレイテッド | 心臓保護ホスホン酸塩およびマロン酸塩 |
US6586414B2 (en) | 2000-03-28 | 2003-07-01 | Medicure International Inc. | Treatment of cerebrovascular disease |
AU2001272263B2 (en) | 2000-07-07 | 2005-12-15 | Medicure International Inc. | Pyridoxine and pyridoxal analogues: cardiovascular therapeutics |
US6897228B2 (en) | 2000-07-07 | 2005-05-24 | Medicure International Inc. | Pyridoxine and pyridoxal analogues: new uses |
US6548519B1 (en) | 2001-07-06 | 2003-04-15 | Medicure International Inc. | Pyridoxine and pyridoxal analogues: novel uses |
JP2006523206A (ja) * | 2003-03-27 | 2006-10-12 | メディキュア インコーポレーテッド | 細胞死の調節 |
CA2585165A1 (en) | 2004-10-28 | 2006-05-18 | Medicure International Inc. | Dual antiplatelet/anticoagulant pyridoxine analogs |
AU2006204563A1 (en) * | 2005-01-05 | 2006-07-13 | Medicure International Inc. | Compounds and methods for regulating triglyceride levels |
FR3038227B1 (fr) | 2015-06-30 | 2018-08-17 | Assistance Publique - Hopitaux De Paris | Formulation effervescente a base de pyridoxal-5-phosphate |
JP7244024B2 (ja) * | 2018-06-25 | 2023-03-22 | 学校法人近畿大学 | ニコチン摂取の影響による血管壁のコラーゲン分解防止剤 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR3373E (fr) | 1904-02-26 | 1904-10-27 | Joseph Louis Felix Garrigou | Procédé de traitement des vidanges et déchets organiques, et appareil d'ensemble permettant sa mise en oeuvre |
FR6707M (hu) * | 1966-04-29 | 1969-02-17 | ||
GB1070120A (en) * | 1966-05-06 | 1967-05-24 | Tanabe Seiyaku Co | Pyridoxine derivative and the preparation thereof |
FR7238M (hu) * | 1968-03-27 | 1969-09-01 | ||
FR2035765A1 (en) * | 1969-03-06 | 1970-12-24 | Inst Rech Scient | Medicaments contg pyridoxine heparinates or - other vitamin b6 heparinates |
JPS5347110B2 (hu) * | 1971-11-02 | 1978-12-19 | ||
FR2176509A2 (en) * | 1972-03-21 | 1973-11-02 | Inst Rech Scient | Pyridoxine p-chlorophenoxyisobutyrate prodn - giving very pure product from corresp acid and pyridoxine |
JPS5018470A (hu) * | 1973-05-31 | 1975-02-26 | ||
FR2260330A1 (en) | 1974-02-07 | 1975-09-05 | Innothera Lab Sa | Pyridoxine N-oxy nicotinate - hypolipaemiant and hypocholesterolemiant of good therapeutic index |
CH607773A5 (en) * | 1974-12-24 | 1978-10-31 | Steigerwald Arzneimittelwerk | Process for the preparation of novel pyridoxine derivatives |
DE2461742C2 (de) * | 1974-12-28 | 1983-01-27 | Steigerwald Arzneimittelwerk Gmbh, 6100 Darmstadt | Pyridoxin-5'-phosphorsäureester-Derivate sowie deren Herstellung und diese Verbindungen enthaltende Arzneimittel |
FR2349330A1 (fr) * | 1976-04-29 | 1977-11-25 | Savini Emile | Composition destinee au traitement des hyperlipidemies |
JPS5347110A (en) * | 1976-10-12 | 1978-04-27 | Osaka Bosui Kensetsusha Kk | Impermeable wall forming method |
-
1987
- 1987-02-18 DE DE19873705549 patent/DE3705549A1/de not_active Withdrawn
-
1988
- 1988-01-20 AT AT88100747T patent/ATE82125T1/de not_active IP Right Cessation
- 1988-01-20 DE DE8888100747T patent/DE3875760D1/de not_active Expired - Fee Related
- 1988-01-20 EP EP88100747A patent/EP0282696B1/de not_active Expired - Lifetime
- 1988-01-20 ES ES88100747T patent/ES2052609T3/es not_active Expired - Lifetime
- 1988-01-28 ZA ZA880577A patent/ZA88577B/xx unknown
- 1988-02-01 EG EG53/88A patent/EG18335A/xx active
- 1988-02-03 DK DK055888A patent/DK55888A/da not_active Application Discontinuation
- 1988-02-16 HU HU88723A patent/HUT47850A/hu unknown
- 1988-02-17 JP JP63032943A patent/JPH0710777B2/ja not_active Expired - Lifetime
- 1988-02-17 KR KR1019880001692A patent/KR950009094B1/ko not_active IP Right Cessation
- 1988-02-18 CA CA000559285A patent/CA1340246C/en not_active Expired - Fee Related
-
1992
- 1992-12-28 GR GR920403159T patent/GR3006693T3/el unknown
-
1994
- 1994-09-02 JP JP6209830A patent/JP2588686B2/ja not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
DE3705549A1 (de) | 1988-09-01 |
DE3875760D1 (de) | 1992-12-17 |
KR950009094B1 (ko) | 1995-08-14 |
DK55888A (da) | 1988-08-19 |
GR3006693T3 (hu) | 1993-06-30 |
JPS63203621A (ja) | 1988-08-23 |
EG18335A (en) | 1992-09-30 |
JPH07238020A (ja) | 1995-09-12 |
ES2052609T3 (es) | 1994-07-16 |
HUT47850A (en) | 1989-04-28 |
ATE82125T1 (de) | 1992-11-15 |
KR880009649A (ko) | 1988-10-04 |
JP2588686B2 (ja) | 1997-03-05 |
CA1340246C (en) | 1998-12-15 |
EP0282696A3 (en) | 1989-06-14 |
DK55888D0 (da) | 1988-02-03 |
EP0282696B1 (de) | 1992-11-11 |
JPH0710777B2 (ja) | 1995-02-08 |
EP0282696A2 (de) | 1988-09-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EG18335A (en) | Use of pyridoxine derivatives in the prevention and treatment of hyperlipidaemia and antherosclerosis | |
KR950009098B1 (en) | Pharmaceutical composition for use in treating clot formation | |
AU2490297A (en) | Use of strontium salts for the production of pharmaceutical compositions intended for the treatment of arthrosis | |
HU896498D0 (en) | Process for preparation of low volatility salts | |
AU7316591A (en) | Use of 3-guanidinopropionic acid in the treatment and prevention of metabolic disorders | |
GB8806737D0 (en) | Therapeutic composition & method | |
DE69230526D1 (de) | Polyaminosäure-dispergiermittel | |
AU8188087A (en) | Variants of hirudin, their use and their preparation | |
DE3273611D1 (en) | Infusion solutions for heart therapy | |
AU2005188A (en) | Pharmaceutical composition for intranasal administration comprising gh-releasing hormone, a cholinergic agonist and in case a bile salt | |
GR900300043T1 (en) | Use of the enzyme-cofactor nadph in the preparation of a pharmaceutical, pharmaceutical and preparation thereof | |
HU9403383D0 (en) | Diamine salts of clavulanic acid | |
AU639097B2 (en) | Medicament for treating hyperlipidaemia and/or atherosclerosis | |
IN168234B (hu) | ||
GR3005222T3 (hu) | ||
AU3934689A (en) | New furylthiazole derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same | |
IL81549A0 (en) | Pharmaceutical compositions containing glycerophosphoryl-o-serine or a salt thereof,certain such novel salts and their preparation | |
AU589148B2 (en) | Medicament for the treatment of acquired immune deficiency syndrome and corresponding pharmaceutical compositions and method of treatment | |
EP0286802A3 (en) | Use of ofloxacin in treating or preventing locally periodontal disease | |
HU9200025D0 (en) | Medical preparations for treating depression | |
ZA871140B (en) | Synergistic chemical compositions for treating salmonellosis | |
GB2206338B (en) | Fine filler dentifrice | |
DE3869772D1 (hu) | ||
AU6686490A (en) | Pesticide composition | |
IT1174592B (it) | Composizione utile nel trattamento della diarrea |